Stay informed with the latest litigation news. Explore now

IP Verse

Regeneron Pharmaceuticals vs. Amgen - ORD_10398/2024

Explore detailed information on the case number ORD_10398/2024 involving Regeneron Pharmaceuticals and Amgen which was filed on 27 Feb, 2024.

Case Details

    Case Number:

    ORD_10398/2024

    Filing Date:

    27 Feb, 2024

    Proceeding Type:

    Order

    Action/Application:

    Generic Order

    Plaintiffs:

    • Regeneron Pharmaceuticals Inc

    Defendants:

    • Amgen Inc

    Court Division:

    First Instance, Local Division - Munich

Case Decision

Decision pending - set alert to receive updates

More cases involving Regeneron Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Sep 11, 2025
Case NumberFiling DatePlaintiffsDefendants
App_34318/2025Aug 5, 2025Regeneron Pharmaceuticals, Sanofi Biotechnology -
App_33251/2025Jul 21, 2025Sanofi Biotechnology, Regeneron Pharmaceuticals -
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Sep 11, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
ORD_16586/2025Apr 4, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
ACT_10334/2025Feb 28, 2025Regeneron Pharmaceuticals Inc., Sanofi Biotechnology SasAmgen S.R.L., Amgen S.A.S., Amgen Nv, Amgen Gmbh, Amgen Inc., Amgen Europe B.V., Amgen B.V.